3000 ORAL Randomised phase III study of capecitabine, oxaliplatin and bevacizumab (CAPOX-B) with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim safety analysis

✍ Scribed by J. Tol; M. Koopman; C.J. Rodenburg; A. Cats; G.J. Creemers; C.A.M. de Swart; F.L.G. Erdkamp; L. Mol; N.F. Antonini; C.J.A. Punt

• Book ID: 118625770
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 76 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)70928-x